A Win for Science, with Profound Implications for Industry: FDA Rejects MDMA
Mad in America
AUGUST 14, 2024
Perhaps because MDMA-assisted therapy isn’t a simple drug to be prescribed by psychiatrists. Moreover, Lykos is a small company bringing it to market, one that emerged out of a psychedelic research nonprofit (MAPS). And since SSRIs are prescribed for PTSD, this would be a treatment competing with pharmaceutical giants.
127 
Let's personalize your content